<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Reports of Biochemistry and Molecular Biology</title>
<title_fa></title_fa>
<short_title>rbmb.net</short_title>
<subject>Basic Sciences</subject>
<web_url>http://rbmb.net</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-3480</journal_id_issn>
<journal_id_issn_online>2322-3480</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/rbmb</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2021</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>9</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>PTGS2 Over-expression: A Colorectal Carcinoma Initiator Not an Invasive Factor</title>
	<subject_fa>زیست شناسی ملکولی</subject_fa>
	<subject>Molecular Biology</subject>
	<content_type_fa>مقالات اصلی</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;&lt;em&gt;Bac&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;kground:&lt;/em&gt;&lt;/strong&gt; Cyclooxygenase-2 (COX-2) main product is Prostaglandin E2 (PGE2) which cause mitogenesis and inflammation. COX-2 is the product of prostaglandin-endoperoxide synthase 2 (&lt;em&gt;PTGS2&lt;/em&gt;) gene expression. COX-2 dysregulation can cause angiogenesis, differentiation, and promotion of cancer and its suppression related to control of the tumor&amp;#39;s size, number, and cell shape. This study focused on the association of COX-2 expression with colorectal carcinoma (CRC) among Iranian patients on mRNA level and in the Cancer Genome Atlas Program (TCGA) colon and rectum RNAseq dataset, and its relation with pathological features.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Methods:&lt;/em&gt;&lt;/strong&gt; &lt;em&gt;PTGS2&lt;/em&gt; expression was assayed by quantitative-PCR method from 90 tissue samples collected from 45 participants. The control samples come from the non-tumor area of the same patients. The data analyzed based on &amp;Delta;&amp;Delta;Cq. The &lt;em&gt;PTGS2&lt;/em&gt;-RNAseq data extracted and analyzed by UCSC Xena browser, and its association assessed the occurrence of CRC and invasive-features.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Results:&lt;/em&gt;&lt;/strong&gt; &lt;em&gt;PTGS2&lt;/em&gt; showed very significant over-expression in tumor tissues (p&lt; 0.0001) with an N-fold expression of 2.25. But, there was not any significant association between &lt;em&gt;PTGS2&lt;/em&gt; and CRC invasive-pathological features such as Lymphatic, vascular and perineural invasion, the Grades of cancer, and Pathologic-M in both parts of this study.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Conclusions:&lt;/em&gt;&lt;/strong&gt; The increase in &lt;em&gt;PTGS2&lt;/em&gt; is related to the occurrence of CRC among patient samples. But in both part of this study, &lt;em&gt;PTGS2&lt;/em&gt; is not an invasive factor, and it does not affect the cell differentiation of tumors and metastasis. Based on the high N-fold for patient samples, it can be a strong candidate as a CRC initiator biomarker.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Cyclooxygenase-2, Gene expression profiling, Neoplasm invasion, Prostaglandins, TCGA-data.</keyword>
	<start_page>442</start_page>
	<end_page>451</end_page>
	<web_url>http://rbmb.net/browse.php?a_code=A-10-631-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Tahereh</first_name>
	<middle_name></middle_name>
	<last_name>Zahedi</last_name>
	<suffix></suffix>
	<first_name_fa>Tahereh</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Zahedi</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>zahedi.tahereh@gmail.com</email>
	<code>100319475328460017758</code>
	<orcid>100319475328460017758</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Molecular and Cell Biology, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Mazandaran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Abasalt</first_name>
	<middle_name></middle_name>
	<last_name>Hosseinzadeh Colagar</last_name>
	<suffix></suffix>
	<first_name_fa>Abasalt</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Hosseinzadeh Colagar</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>acolagar@yahoo.com</email>
	<code>100319475328460017759</code>
	<orcid>100319475328460017759</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Molecular and Cell Biology, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Mazandaran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Habibollah</first_name>
	<middle_name></middle_name>
	<last_name>Mahmoodzadeh</last_name>
	<suffix></suffix>
	<first_name_fa>Habibollah</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Mahmoodzadeh</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hmahmoodzadeh@tums.ac.ir</email>
	<code>100319475328460017760</code>
	<orcid>100319475328460017760</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Surgical Oncology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
